Exisulind Versus Placebo After Surgical Removal of the Prostate

NCT00166426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Exisulind

Sponsor

Mayo Clinic

Collaborators

[object Object]